A Phase II Study of HR070803 in the Treatment of Advanced Esophageal Cancer
Clinical trial NCT05425472 · UNKNOWN
Trial details
- NCT number
- NCT05425472
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-27
- Primary completion
- 2023-01-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.